Spark Therapeutics Competitors and Similar CompaniesClear all
Spark Therapeutics's competitors and similar companies include Bruker Cellular Analysis and ImmusanT.
 Bruker Cellular Analysis Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products. |  ImmusanT ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases. | ||
Founding Date | Founding Date 2013 | Founding Date 2011 | Founding Date 2010 |
Type | Type Public | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Philadelphia, US HQ | Locations Emeryville, US HQ | Locations Cambridge, US HQ |
Employees | Employees 36817% increase | Employees 1391% decrease | Employees 2 |
Financial | |||
Revenue (est.) | Revenue (est.) $64.7m (FY, 2018) | Revenue (est.) $78.6m (FY, 2022) | Revenue (est.) N/A |
Net income | Net income ($78.8m) (FY, 2018) | Net income ($98m) (FY, 2022) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 122.8m | Total funding raised $ 124.7m | Total funding raised $ 72.8m |
For sources of this data, please see the company profile
View Company Profiles
Bruker Cellular Analysis
HQ
Emeryville, US
Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products.
View companyImmusanT
HQ
Cambridge, US
Employees
2
ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases.
View company